266 related articles for article (PubMed ID: 10063271)
21. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.
Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J
Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954
[TBL] [Abstract][Full Text] [Related]
22. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
[TBL] [Abstract][Full Text] [Related]
23. Genetic alterations associated with the evolution and progression of astrocytic brain tumours.
Ohgaki H; Schäuble B; zur Hausen A; von Ammon K; Kleihues P
Virchows Arch; 1995; 427(2):113-8. PubMed ID: 7582239
[TBL] [Abstract][Full Text] [Related]
24. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
[TBL] [Abstract][Full Text] [Related]
25. Influence of p53 mutations on prognosis of patients with glioblastoma.
Shiraishi S; Tada K; Nakamura H; Makino K; Kochi M; Saya H; Kuratsu J; Ushio Y
Cancer; 2002 Jul; 95(2):249-57. PubMed ID: 12124823
[TBL] [Abstract][Full Text] [Related]
26. Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternate pathways of tumorigenesis.
Chozick BS; Weicker ME; Pezzullo JC; Jackson CL; Finkelstein SD; Ambler MW; Epstein MH; Finch PW
Cancer; 1994 Jan; 73(2):406-15. PubMed ID: 8293408
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
[TBL] [Abstract][Full Text] [Related]
28. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S
Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141
[TBL] [Abstract][Full Text] [Related]
29. p53 protein in pediatric malignant astrocytomas: a study of 21 patients.
Bhattacharjee MB; Bruner JM
J Neurooncol; 1997 May; 32(3):225-33. PubMed ID: 9049884
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of p53 gene and protein alterations in human astrocytic tumors.
Louis DN; von Deimling A; Chung RY; Rubio MP; Whaley JM; Eibl RH; Ohgaki H; Wiestler OD; Thor AD; Seizinger BR
J Neuropathol Exp Neurol; 1993 Jan; 52(1):31-8. PubMed ID: 8381161
[TBL] [Abstract][Full Text] [Related]
31. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
[TBL] [Abstract][Full Text] [Related]
32. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
33. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
34. TP53 mutations in malignant astrocytomas.
Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic alterations in radiation-induced astrocytomas.
Brat DJ; James CD; Jedlicka AE; Connolly DC; Chang E; Castellani RJ; Schmid M; Schiller M; Carson DA; Burger PC
Am J Pathol; 1999 May; 154(5):1431-8. PubMed ID: 10329596
[TBL] [Abstract][Full Text] [Related]
36. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.
van Meyel DJ; Ramsay DA; Casson AG; Keeney M; Chambers AF; Cairncross JG
J Natl Cancer Inst; 1994 Jul; 86(13):1011-7. PubMed ID: 8007011
[TBL] [Abstract][Full Text] [Related]
37. The lack of a role for p53 in astrocytomas in pediatric patients.
Litofsky NS; Hinton D; Raffel C
Neurosurgery; 1994 Jun; 34(6):967-72; discussion 972-3. PubMed ID: 8084407
[TBL] [Abstract][Full Text] [Related]
38. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
39. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
[TBL] [Abstract][Full Text] [Related]
40. p53 allelic imbalance in astrocytoma detected using fluorescent PCR of microsatellite repeat polymorphisms.
al-Sarraj S; Bridges LR; Cawkwell L; Lewis FA; Quirke P
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):344-51. PubMed ID: 7494603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
